Trevi Therapeutics (TRVI) Prepaid Assets (2018 - 2026)
Trevi Therapeutics (TRVI) posted quarterly Prepaid Assets of $2.1 million for Q1 2026, up 154.44% year-over-year from $834000.0 in Q1 2025, and up 68.01% quarter-over-quarter from $1.3 million in Q4 2025.
Trevi Therapeutics (TRVI) Prepaid Assets (2018 - 2026) Analysis & Trends
Trevi Therapeutics' Prepaid Assets history runs 9 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 154.44% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $2.1 million (up 154.44% YoY), while the FY2025 annual figure was $1.3 million, up 34.5% from the prior year.
- Prepaid Assets for Q1 2026 stood at $2.1 million, up from $1.3 million in the prior quarter.
- The five-year high for Prepaid Assets was $4.0 million in Q3 2023, with the low at $477000.0 in Q1 2022.
- The 5-year median for Prepaid Assets is $1.3 million (2025), against an average of $1.4 million.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets surged 237.74% in 2023, then plunged 70.88% in 2024.
- Trevi Therapeutics' Prepaid Assets stood at $795000.0 in 2022, then rose by 20.13% to $955000.0 in 2023, then declined by 1.68% to $939000.0 in 2024, then soared by 34.5% to $1.3 million in 2025, then surged by 68.01% to $2.1 million in 2026.
- Business Quant data shows TRVI's Prepaid Assets at $2.1 million in Q1 2026, $1.3 million in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Trevi Therapeutics | 2.63 Bn | 2.63 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.26 Mn |
| Mar 31, 2026 | 2.12 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 1.77 Mn |
| Mar 31, 2025 | 834,000.00 |
| Dec 31, 2024 | 939,000.00 |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 830,000.00 |
| Mar 31, 2024 | 721,000.00 |
| Dec 31, 2023 | 955,000.00 |
| Sep 30, 2023 | 4.04 Mn |
| Jun 30, 2023 | 2.08 Mn |
| Mar 31, 2023 | 1.61 Mn |
| Dec 31, 2022 | 795,000.00 |
| Sep 30, 2022 | 1.29 Mn |
| Jun 30, 2022 | 1.65 Mn |
| Mar 31, 2022 | 477,000.00 |
| Dec 31, 2021 | 241,000.00 |
| Sep 30, 2021 | 1.39 Mn |